Evidence map›Paper›PMID 30389906›Full record

ArticleCell death & disease2018

Phosphatidylserine is a marker for axonal debris engulfment but its exposure can be decoupled from degeneration.

Vered Shacham-Silverberg, Hadas Sar Shalom, Ron Goldner, Yarden Golan-Vaishenker, Neta Gurwicz, Irena Gokhman, Avraham Yaron

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Microglia and immune signaling as architects of the brain.Frontiers in cellular neuroscience · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. TheProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Mast cell-derived BH4 is a critical mediator of postoperative pain.bioRxiv : the preprint server for biology · 2023
    Article
  16. A duplex structure of SARM1 octamers stabilized by a new inhibitor.Cellular and molecular life sciences : CMLS · 2022
    Article
  17. Macrophage depletion blocks congenital SARM1-dependent neuropathy.The Journal of clinical investigation · 2022
    Article
  18. Article
  19. Review
  20. Phagocytosis and self-destruction break down dendrites ofProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Vered Shacham-SilverbergDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel.
Hadas Sar ShalomDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel.
Ron GoldnerDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel.
Yarden Golan-VaishenkerDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel.
Neta GurwiczDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel.
Irena GokhmanDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel.
Avraham YaronDepartment of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, 76100, Israel. avraham.yaron@weizmann.ac.il.
Weizmann Institute of Science · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apoptotic cells expose Phosphatidylserine (PS), that serves as an "eat me" signal for engulfing cells. Previous studies have shown that PS also marks degenerating axonsduring developmental pruning or in response to insults (Wallerian degeneration), but the pathways that control PS exposure on degenerating axons are largely unknown. Here, we used a series of in vitro assays to systematically explore the regulation of PS exposure during axonal degeneration. Our results show that PS exposure is regulated by the upstream activators of axonal pruning and Wallerian degeneration. However, our investigation of signaling further downstream revealed divergence between axon degeneration and PS exposure. Importantly, elevation of the axonal energetic status hindered PS exposure, while inhibition of mitochondrial activity caused PS exposure, without degeneration. Overall, our results suggest that the levels of PS on the outer axonal membrane can be dissociated from the degeneration process and that the axonal energetic status plays a key role in the regulation of PS exposure.

Indexed as

Adenosine TriphosphateAnimalsApoptosisArmadillo Domain ProteinsAxotomybcl-2-Associated X ProteinBiomarkersCytoskeletal ProteinsEmbryo, MammalianGanglia, SpinalGene ExpressionMiceMice, KnockoutMicrofluidic Analytical TechniquesNerve Growth FactorNeuronal PlasticityAdenosine TriphosphateArmadillo Domain ProteinsBax protein, mousebcl-2-Associated X ProteinBiomarkersCytoskeletal ProteinsNerve Growth FactorPhosphatidylserinesSARM1 protein, mouseVincristine

Identifiers

PMID30389906
PMCPMC6214901
OpenAlexW2898910665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.